Ocwen Financial Announces Operating Results for First Quarter 2020
- Reported a Net Loss of
$25.5 million and a Pre-tax Loss of$87.3 million for the first quarter of 2020 and ended the quarter with$429.9 million of total stockholders' equity, or a book value per share of$3.32 . Financial results included$78 million unfavorable impact on pre-tax loss due to changes in interest rates and a$62 million income tax benefit relating to changes in NOL utilization rules under the CARES Act.
- Pre-tax income before notable items of
$2 million , includes a$7 million unfavorable impact of COVID-19 during the quarter and$3 million unfavorable impact due to seasonal changes in employee costs and escrow balances versus the fourth quarter.
- Ended the quarter with
$263.6 million of cash despite$58.8 million of MSR financing margin calls and$133.6 million debt repayment.
- Granted 114,600 active COVID-19 forbearance plans, or 8.5% of our total loans serviced as of
April 30, 2020 for which we are directly obligated to advance on roughly 27% of these loans which is 7% of the Company’s total owned servicing portfolio.
- Originated and purchased MSR UPB of approximately
$4 billion and grew our owned servicing portfolio to$77.2 billion . Originated approximately$11 billion of annualized volume across all retail and flow channels in March.
First quarter 2020 Results
Pre-tax loss for the first quarter of 2020 was
First quarter 2020 Business Highlights
- We closed and originated MSRs with
$2.9 billion of unpaid principal balance in the first quarter of 2020.
- We completed 8,325 modifications in the quarter to help struggling families stay in their homes.
- Our forward MSR hedge strategy, which includes our reverse MSR, forward lending pipeline and derivative hedge instruments, performed as expected with total coverage against our forward MSR equal to 43% of the decline in our forward MSR value.
- Our operating expenses for the quarter were
$137 million , which were down from our operating expenses of$206 million for the second quarter of 2018; we realized adjusted annualized run rate cost savings of$395 million as compared to the adjusted annualized run rate costs ofOcwen andPHH Corporation combined for the second quarter 2018.
- Delinquencies, excluding the impact of loans in forbearance due to COVID-19, decreased from 6.3% at
December 31, 2019 to 6.1% atMarch 31, 2020 , primarily driven by loss mitigation efforts.
- The constant pre-payment rate (CPR) decreased from 16.7% in the fourth quarter of 2019 to 14.7% in the first quarter of 2020 due to lower interest rates. In the first quarter of 2020, prime CPR was 17.2%, and non-prime CPR was 12.9%.
- We elected the fair value option for future draw commitments for HECM loans purchased or originated before
January 1, 2019 and recorded a$47.0 million adjustment to retained earnings as ofJanuary 1, 2020 .
- Repurchased 5.7 million shares in the quarter for a total cost of
$4.6 million
Webcast and Conference Call
Ocwen will host a webcast and conference call on
About
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may be identified by a reference to a future period or by the use of forward-looking terminology. Forward-looking statements are typically identified by words such as “believe”, “expect”, “foresee”, “forecast”, “anticipate”, “intend”, “estimate”, “goal”, “strategy”, “plan” “target” and “project” or conditional verbs such as “will”, “may”, “should”, “could” or “would” or the negative of these terms, although not all forward-looking statements contain these words.
Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Our business has been undergoing substantial change and as a result of the COVID-19 pandemic, we are in the midst of a period of significant capital markets volatility and a rapidly evolving mortgage lending and servicing environment, which has magnified such uncertainties. Readers should bear these factors in mind when considering such statements and should not place undue reliance on such statements.
Forward-looking statements involve a number of assumptions, risks and uncertainties that could cause actual results to differ materially. In the past, actual results have differed from those suggested by forward looking statements and this may happen again.
Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to, uncertainty relating to the impacts of the COVID-19 pandemic, including with respect to the response of the
Note Regarding Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, such as our references to adjusted annualized run rate cost savings and pre-tax income excluding income statement notables. We believe these non-GAAP financial measures provide a useful supplement to discussions and analysis of our financial condition. We believe these non-GAAP financial measures provide an alternative way to view certain aspects of our business that is instructive. Below, we present supplemental information (including reconciliations) relating to certain illustrative adjustments to GAAP expenses, and pre-tax income (loss). We believe this information is instructive as an alternative way to view certain aspects of our business. In addition, management believes that these presentations may assist investors with understanding and evaluating our cost re-engineering efforts and other initiatives to drive improved financial performance. However, the adjustments we make to GAAP expenses and pre-tax income (loss) should not be analyzed in isolation or as a substitute to analysis of our GAAP expenses and pre-tax income (loss). There are certain limitations to the analytical usefulness of the adjustments we make to GAAP expenses and pre-tax income (loss) and, accordingly, we rely primarily on our GAAP results and use these adjustments only for purposes of supplemental analysis. For example, annualization of amounts relevant to one quarter may or may not be a good indicator of the relevant full year amount due to facts or circumstances impacting the quarter or the three subsequent quarters, among other factors. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, Ocwen's reported results under accounting principles generally accepted in
FOR FURTHER INFORMATION CONTACT:
Investors: | Media: |
T: (856) 917-3190 | T: (856) 917-0066 |
E: shareholderrelations@ocwen.com | E: mediarelations@ocwen.com |
Residential Servicing Statistics (Dollars in thousands) |
||||||||||||||||||||
At or for the Three Months Ended | ||||||||||||||||||||
2020 |
2019 |
2019 |
2019 |
2019 |
||||||||||||||||
Total unpaid principal balance of loans and REO serviced | $ | 208,761,340 | $ | 212,366,431 | $ | 216,754,784 | $ | 229,283,045 | $ | 251,080,740 | ||||||||||
Non-performing loans and REO serviced as a % of total UPB (1) | 6.1 | % | 6.3 | % | 5.7 | % | 5.5 | % | 4.7 | % | ||||||||||
Prepayment speed (average CPR)(2) (3) | 14.7 | % | 16.7 | % | 17.7 | % | 15.2 | % | 12.5 | % |
(1) Performing loans include those loans that are less than 90 days past due and those loans for which borrowers are making scheduled payments under loan modification, forbearance or bankruptcy plans. We consider all other loans to be non-performing.
(2) Average CPR for the prior three months. CPR measures prepayments as a percentage of the current outstanding loan balance expressed as a compound annual rate.
(3) Average CPR for the three months ended
Segment Results (Dollars in thousands) |
|||||||
For the Three Months Ended |
|||||||
2020 | 2019 | ||||||
Servicing | |||||||
Revenue | $ | 213,555 | $ | 259,274 | |||
MSR valuation adjustments, net | (174,436 | ) | (108,914 | ) | |||
Operating expenses | 80,473 | 156,984 | |||||
Other expense, net | (14,742 | ) | (50,879 | ) | |||
Loss before income taxes | (56,096 | ) | (57,503 | ) | |||
Originations | |||||||
Revenue | 37,647 | 41,091 | |||||
MSR valuation adjustments, net | 316 | (84 | ) | ||||
Operating expenses | 26,958 | 21,247 | |||||
Other income (expense), net | (624 | ) | 100 | ||||
Income before income taxes | 10,381 | 19,860 | |||||
Corporate Items and Other | |||||||
Revenue | 2,640 | 3,523 | |||||
Operating expenses | 29,783 | (7,124 | ) | ||||
Other expense, net | (14,487 | ) | (14,088 | ) | |||
Loss before income taxes | (41,630 | ) | (3,441 | ) | |||
Consolidated loss before income taxes | $ | (87,345 | ) | $ | (41,084 | ) | |
OCWEN FINANCIAL CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in thousands, except per share data) |
|||||||
For the Three Months Ended |
|||||||
2020 | 2019 | ||||||
Revenue | |||||||
Servicing and subservicing fees | $ | 211,483 | $ | 256,616 | |||
Reverse mortgage revenue, net | 22,797 | 32,123 | |||||
Gain on loans held for sale, net | 13,331 | 8,982 | |||||
Other revenue, net | 6,231 | 6,167 | |||||
Total revenue | 253,842 | 303,888 | |||||
MSR valuation adjustments, net | (174,120 | ) | (108,998 | ) | |||
Operating expenses | |||||||
Compensation and benefits | 60,728 | 94,696 | |||||
Servicing and origination | 20,256 | 28,698 | |||||
Professional services | 25,637 | 3,441 | |||||
Technology and communications | 15,193 | 24,435 | |||||
Occupancy and equipment | 11,969 | 16,589 | |||||
Other expenses | 3,431 | 3,248 | |||||
Total operating expenses | 137,214 | 171,107 | |||||
Other income (expense) | |||||||
Interest income | 5,395 | 4,558 | |||||
Interest expense | (29,982 | ) | (26,489 | ) | |||
Pledged MSR liability expense | (6,594 | ) | (43,956 | ) | |||
Other, net | 1,328 | 1,020 | |||||
Total other expense, net | (29,853 | ) | (64,867 | ) | |||
Loss before income taxes | (87,345 | ) | (41,084 | ) | |||
Income tax (benefit) expense | (61,856 | ) | 3,410 | ||||
Net loss | $ | (25,489 | ) | $ | (44,494 | ) | |
Loss per share attributable to Ocwen stockholders | |||||||
Basic and Diluted | $ | (0.19 | ) | $ | (0.33 | ) | |
Weighted average common shares outstanding | |||||||
Basic and Diluted | 134,858,837 | 133,918,986 |
OCWEN FINANCIAL CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Dollars in thousands, except per share data) |
|||||||
2020 |
2019 |
||||||
Assets | |||||||
Cash and cash equivalents | $ | 263,555 | $ | 428,339 | |||
Restricted cash (amounts related to variable interest entities (VIEs) of |
53,177 | 64,001 | |||||
Mortgage servicing rights (MSRs), at fair value | 1,050,228 | 1,486,395 | |||||
Advances, net (amounts related to VIEs of |
1,024,807 | 1,056,523 | |||||
Loans held for sale ( |
246,015 | 275,269 | |||||
Loans held for investment, at fair value (amounts related to VIEs of |
6,591,382 | 6,292,938 | |||||
Receivables, net | 235,305 | 201,220 | |||||
Premises and equipment, net | 37,430 | 38,274 | |||||
Other assets ( |
484,125 | 563,240 | |||||
Total assets | $ | 9,986,024 | $ | 10,406,199 | |||
Liabilities and Equity | |||||||
Liabilities | |||||||
$ | 6,323,091 | $ | 6,063,435 | ||||
Advance match funded liabilities (related to VIEs) | 625,951 | 679,109 | |||||
Other financing liabilities, at fair value (amounts related to VIEs of |
623,049 | 972,595 | |||||
Other secured borrowings, net (amounts related to VIEs |
797,615 | 1,025,791 | |||||
Senior notes, net | 311,290 | 311,085 | |||||
Other liabilities ( |
875,171 | 942,173 | |||||
Total liabilities | 9,556,167 | 9,994,188 | |||||
Stockholders’ Equity | |||||||
Common stock, |
1,296 | 1,349 | |||||
Additional paid-in capital | 553,066 | 556,798 | |||||
Accumulated deficit | (116,993 | ) | (138,542 | ) | |||
Accumulated other comprehensive loss, net of income taxes | (7,512 | ) | (7,594 | ) | |||
Total stockholders’ equity | 429,857 | 412,011 | |||||
Total liabilities and stockholders’ equity | $ | 9,986,024 | $ | 10,406,199 | |||
OCWEN FINANCIAL CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollars in thousands) |
|||||||
For the Three Months Ended |
|||||||
2020 | 2019 | ||||||
Cash flows from operating activities | |||||||
Net loss | $ | (25,489 | ) | $ | (44,494 | ) | |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||
MSR valuation adjustments, net | 174,120 | 108,998 | |||||
Gain on sale of MSRs, net | (286 | ) | (369 | ) | |||
Provision for bad debts | 4,879 | 9,170 | |||||
Depreciation | 3,997 | 8,551 | |||||
Amortization of debt issuance costs | 1,733 | 700 | |||||
Equity-based compensation expense | 746 | 857 | |||||
Gain on valuation of financing liability | (30,697 | ) | (26,237 | ) | |||
Net gain on valuation of mortgage loans held for investment and HMBS-related borrowings | (17,910 | ) | (23,487 | ) | |||
Gain on loans held for sale, net | (13,331 | ) | (11,112 | ) | |||
Origination and purchase of loans held for sale | (831,474 | ) | (304,182 | ) | |||
Proceeds from sale and collections of loans held for sale | 843,178 | 305,322 | |||||
Changes in assets and liabilities: | |||||||
Decrease in advances, net | 29,428 | 91,114 | |||||
Decrease in receivables and other assets, net | 13,642 | 23,627 | |||||
Increase (decrease) in other liabilities | 18,033 | (36,755 | ) | ||||
Other, net | 408 | (1,039 | ) | ||||
Net cash provided by operating activities | 170,977 | 100,664 | |||||
Cash flows from investing activities | |||||||
Origination of loans held for investment | (294,932 | ) | (209,264 | ) | |||
Principal payments received on loans held for investment | 175,095 | 104,630 | |||||
Purchase of MSRs | (29,828 | ) | (48,641 | ) | |||
Proceeds from sale of MSRs | — | 868 | |||||
Proceeds from sale of advances | 105 | 1,070 | |||||
Additions to premises and equipment | (1,072 | ) | (531 | ) | |||
Proceeds from sale of real estate | 2,814 | 1,682 | |||||
Other, net | 491 | (1,157 | ) | ||||
Net cash used in investing activities | (147,327 | ) | (151,343 | ) | |||
OCWEN FINANCIAL CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS — (continued) (Dollars in thousands) |
|||||||
For the Three Months Ended |
|||||||
2020 | 2019 | ||||||
Cash flows from financing activities | |||||||
Repayment of advance match funded liabilities, net | (53,158 | ) | (128,900 | ) | |||
Proceeds from mortgage loan warehouse facilities and other secured borrowings | 1,330,667 | 616,891 | |||||
Repayment of mortgage loan warehouse facilities and other secured borrowings | (1,478,616 | ) | (727,711 | ) | |||
Proceeds from issuance of additional senior secured term loan (SSTL) | — | 119,100 | |||||
Repayment of SSTL borrowings | (126,066 | ) | (6,358 | ) | |||
Payment of debt issuance costs related to SSTL | (7,267 | ) | (1,284 | ) | |||
Proceeds from sale of MSRs accounted for as a financing | — | 577 | |||||
Proceeds from sale of Home Equity Conversion Mortgages (HECM, or reverse mortgages) accounted for as a financing (HMBS-related borrowings) | 312,249 | 210,563 | |||||
Repayment of HMBS-related borrowings | (172,429 | ) | (102,389 | ) | |||
Repurchase of common stock | (4,605 | ) | — | ||||
Other, net | (33 | ) | (253 | ) | |||
Net cash used in financing activities | (199,258 | ) | (19,764 | ) | |||
Net decrease in cash, cash equivalents and restricted cash | (175,608 | ) | (70,443 | ) | |||
Cash, cash equivalents and restricted cash at beginning of year | 492,340 | 397,010 | |||||
Cash, cash equivalents and restricted cash at end of period (1) | $ | 316,732 | $ | 326,567 | |||
(1) Cash and restricted cash as of |
Non-GAAP Financial Measures:
In the table titled “Expenses Excluding MSR Valuation Adjustments, net, and Expense Notables”, we adjust GAAP expenses to exclude MSR Valuation Adjustments, net for the following expenses (Expense Notables) for (1) expense related to severance, retention and other cost re-engineering actions, (2) certain significant legal and regulatory settlement expense items, (3)
Expenses Excluding MSR Valuation Adjustments, net, and Expense Notables
($ in millions) | Q2’18 | Q1’20 | ||||||||||
OCN + PHH (Annualized) |
OCN | OCN (Annualized) |
||||||||||
I | Expenses (as reported) (a) | 1,107 | ||||||||||
II | Reclassifications (b) | 5 | ||||||||||
III | Deduction of MSR valuation adjustment, net | (132) | ||||||||||
IV | Operating Expenses (Expenses excluding MSR Valuation Adjustments, net) (I+II+III) (c) | 979 | 137 | 549 | ||||||||
Adjustments for Notables | ||||||||||||
Re-engineering costs | (32) | (3) | ||||||||||
Significant legal and regulatory settlement expenses | (20) | (4) | ||||||||||
(22) | (3) | |||||||||||
NRZ consent process expenses | (2) | 1 | ||||||||||
PHH acquisition and integration planning expenses | (8) | - | ||||||||||
Expense recoveries | 23 | - | ||||||||||
Other | (1) | 2 | ||||||||||
V | Expense Notables | (63) | (7) | Annualized Savings | ||||||||
VI | Expenses excluding MSR Valuation Adjustments, net, and Expense Notables (IV+V) | 916 | 130 | 521 | (395) |
(a) Q2’18 expenses as per OCN Form 10-Q of
(b) Reclassifications made to PHH reported expenses to conform to Ocwen presentation
(c) OCN changed the presentation of expenses in Q4’ 19 to separately report MSR valuation adjustments, net from operating expenses
In the table titled “Income Statement Notables”, we show certain illustrative adjustments to GAAP pre-tax income/(loss) for the following factors (1) Expense Notables (excluding MSR Valuation Adjustments, net), (2) changes in fair value of our Non-Agency MSRs due to changes in interest rates, valuation inputs and other assumptions, (3) changes in fair value of our Agency MSRs due to changes in interest rates, valuation inputs and other assumptions, net of hedge positions, (4) offsets to changes in fair value of our MSRs in our NRZ financing liability due to changes in interest rates, valuation inputs and other assumptions, (5) changes in fair value of our reverse originations portfolio due to changes in interest rates, valuation inputs and other assumptions, (6) gains related to exercising servicer call rights, (7) certain other costs, including pension benefits (collectively, Other) and (8) amortization of NRZ lump-sum cash payments consistent with the intent of providing management and investors with a supplemental means of evaluating our pre-tax income/(loss). Amounts included in Pre-Tax Loss excluding Income Statement Notables and Amortization of NRZ Lump-sum Cash Payments are expected to vary in each period due to changes in interest rates and other factors.
Income Statement Notables
($ in millions) | Q2’18 | Q1’20 | |||||||
OCN + PHH (Annualized) |
OCN | OCN (Annualized) |
|||||||
I | Reported Pre-tax Income / (Loss) (a) | (253) | (87) | (349) | |||||
Adjustments for Notables | |||||||||
Expenses Notables (from prior table) | 7 | ||||||||
Non-Agency MSR FV Change (b) | (10) | ||||||||
Agency MSR FV Change, net of macro hedge (b) | 133 | ||||||||
NRZ MSR Liability FV Change (Interest Expense) | (32) | ||||||||
Reverse FV Change | (12) | ||||||||
Other | 5 | ||||||||
II | Total Income Statement Notables | 72 | 89 | ||||||
III | Pre-Tax Income / (Loss) excluding Income Statement Notables (I+II) | (181) | 2 | 8 | |||||
IV | Amortization of NRZ Lump-sum Cash Payments | (141) | (25) | ||||||
V | Pre-Tax Loss excluding Income Statement Notables and Amortization of NRZ Lump-sum Cash Payments (III+IV) (c) | (322) | (23) | (94) |
(a) Q2’18 pre-tax loss as per respective Forms 10-Q filed on
(b) FV changes that are driven by changes in interest rates, valuation inputs or other assumptions, net of unrealized gains / (losses) on macro hedge. Non-Agency = Total MSR excluding GNMA & GSE MSRs. Agency = GNMA & GSE MSRs
(c) Represents OCN and PHH combined pre-tax loss excluding income statement notables and amortization of NRZ lump-sum cash payments
Source: Ocwen Financial Corp.